ArticleUpdates in surgery2026
Impact of Surgical extent on survival in pulmonary typical carcinoids: a retrospective analysis.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The lesser the better? A systematic review and meta-analysis of resection strategy in lung neuroendocrine tumors.Journal of neuroendocrinology · 2026Pooled it
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
While surgical resection of pulmonary typical carcinoid is the primary curative treatment, the optimal extent of resection remains debated, with limited data on survival outcomes and prognostic factors guiding management. This study compared surgical resections of typical carcinoids and evaluated survival and recurrence rates. It also seeks to identify negative prognostic factors to improve the management. A single-center retrospective study analyzed data from patients who underwent surgery for typical carcinoid between 1998 and 2023. The surgery was divided into three groups: atypical segmentectomies, typical segmentectomies, and lobectomies. Clinical and pathological characteristics, perioperative outcomes, and survival rates were assessed. The survival curves were generated using the Kaplan-Meier method, and Cox regression analysis identified prognostic factors for overall survival (OS). Of the 524 patients, 187 (35.7%) were typical carcinoid. Among them, 20% underwent atypical segmentectomy, 3% underwent typical segmentectomy, and 77% underwent lobectomy. The 5-year OS rate was 86%. Recurrence was observed in two patients, all in the lobectomies. The number of mitoses (p = 0.026) and nodal metastases (p = 0.0002) were negative prognostic factors for OS. No significant difference between the surgical approaches was found for OS (Log-rank test = 0.48) or disease-free survival (DFS) (Log-rank test = 0.76). While lobectomy remains the most commonly performed procedure for typical carcinoid, none of the evaluated surgical approaches significantly influenced OS or DSF. Notably, mitoses and nodal metastases emerged as key negative prognostic factors.
Indexed as
Identifiers
40560517What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.